Short-Term Challenges Persist, While Long-Term Health Convergence Offers Growth Opportunities

BMI View: The Czech Republic's disease and drug consumption profile illustrates a considerable gap between this market and Western Europe, suggesting that the population's demand for high value innovative medicines will continue until convergence. However, the health of the Czech population remains superior to that of the less-developed markets of Eastern and South-Eastern Europe, demonstrating that demand in these regions will be even higher. However, governments' short-term ability to provide these medicines remains a key challenge.

To read the full article, please choose one of the following options: